Germline loss-of-function mutations in SMARCE1 were identified in familial spinal meningiomas in 2013 by Smith et al. [22] and seem to be highly linked to the clear cell subtype [23, 26]. This evidence concerns the gene SMARCE1 and spinal meningioma.